Welcome to SPP2395
SPP2395 is a collaboratively supported priority programme on microglia research.
With more than 30 principal investigators in two funding periods, we are driving
36 innovative projects across
more than 20 research institutes in Germany, Israel, the United Kingdom, Switzerland and Finland.
Together, we advance rigorous, transparent science to deepen our understanding of microglia in health and disease.
Our Mission
Microglia are the resident macrophages of the CNS, coordinating homeostatic regulation and mounting first-line immune responses. After two decades revealing their heterogeneity, the field is moving beyond simple “homeostatic” versus “disease-associated” labels toward context-aware biology in intact tissue. SPP2395 prioritizes in vivo investigation and the translation of preclinical insights using human post-mortem tissue, humanized mouse models, iPSC-derived human microglia, and patient data.
News
German Society for Neuroimmunology (DGNIM)
15.04.2026. The German Society for Neuroimmunology (DGNIM) e.V. has officially been founded! After intensive preparation, many discussions, and a great deal of commitment, what has been growing for a long time is now becoming visible. With DGNIM, we aim to create a platform that connects research, fosters innovation, and brings together people in the field of neuroimmunology. Now things are really getting started – and we warmly invite you to become part of this initiative and help shape the future of neuroimmunology.
You can find all information about membership on our website:
https://dgnim.de/
Also follow us on LinkedIn:
LinkedIn: DGNIM
Recent Publications
-
Cerebral ischaemic stroke results in altered mucosal antibody responses and host-commensal microbiota interactions
-
Neuron subtypes have distinct mitochondrial transport in axons and vulnerability to tau in vivo
Participating Institutions
Berlin Institute of Health
Center for Molecular Neurobiology Hamburg
Charité Berlin
Christian-Albrechts-Universität zu Kiel
DZNE Bonn
DZNE München
Experimental Research in Stroke and Inflammation
Helmholtz-Zentrum für Infektionsforschung
Imperial College London
Institute for Stroke and Dementia Research
LMU Klinikum München
LMU München
Mannheim Institute for Innate Immunoscience
Max Delbrück Center Berlin
Medizinische Universität Wien
TU Braunschweig
TU München
Uniklinik Heidelberg
Universität zu Köln
Universitätsklinikum Bonn
Universitätsklinikum Freiburg
Universitätsklinikum Hamburg-Eppendorf
Universitätsklinikum Jena
Universitätsklinikum Leipzig
Universitätsklinikum Schleswig Holstein
Universitätsmedizin Göttingen
Universitätsmedizin Mainz
Université de Genève
University of Turku
Weizmann Institute of Science
SPP2395 PREMIER Wiki 


